Cavalier Investments »

Vertex Pharmaceuticals Incorporated shares owned by Cavalier Investments

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cavalier Investments from 13F filings

Historical chart of Cavalier Investments investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Cavalier Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cavalier Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.4M 7.3k 465.08
2024-06-30 $3.2M 6.9k 468.72
2024-03-31 $2.8M 6.7k 418.01
2023-09-30 $2.2M 6.2k 347.74
2023-06-30 $2.1M 6.0k 351.91

More positions owned by Cavalier Investments

Eli Lilly & Co. (LLY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Communication (XLC)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Semiconductr Etf (SMH)
Vanguard World Financials Etf (VFH)
Howmet Aerospace (HWM)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)

View all positions for Cavalier Investments

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Morgan Stanley
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated